@article{f654bb10d2274080a0beeb8d610a4e72,
title = "Serology assays to manage COVID-19",
author = "Florian Krammer and Viviana Simon",
note = "Funding Information: The authors are supported by the National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVIC; 75N93019C00051), the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS; HHSN272201400008C), institutional funding, and philanthropic donations. The SARS-CoV-2 reagents developed in our labs are freely available to the scientific community (www.beiresources.org/). Mount Sinai is in the process of commercial licensing of assays described here and has filed for patent protection.",
year = "2020",
month = jun,
day = "5",
doi = "10.1126/science.abc1227",
language = "English",
volume = "368",
pages = "1060--1061",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "6495",
}